Clinical Trial Update: Continued Antiretroviral Therapy With Abacavir, Amprenavir and Efavirenz [Phase 2]

View source ↗

Summary

This clinical trial update reports on a Phase 2 study of continued antiretroviral therapy with abacavir, amprenavir and efavirenz for HIV infection.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Amprenavir (amprenavir)
• EFAVIRENZ (efavirenz)
• abacavir (abacavir)

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: HIV Infection | Phase 2 | Status: COMPLETED